CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenue
Operating expenses:
General and administrative (including stock-based compensation)	866,494	491,133
Depreciation	330	248
Research and development (including stock-based compensation)	28,443	61,809
Total operating expenses	895,267	553,190
Loss from operations	(895,267)	(553,190)
Other (income) expense:
Interest income	(1,935)	(1,494)
Interest expense	26,095	112,180
Total other expense	24,160	110,686
Net loss	(919,427)	(663,876)
Net loss attributable to the noncontrolling interest		506
Net loss applicable to Bion's common stockholders	$ (919,427)	$ (663,370)
Net loss applicable to Bion's common stockholders per basic and diluted common share	$ (0.02)	$ (0.02)
Weighted-average number of common shares outstanding:
Basic and diluted	43,451,846	40,719,692